Scarlett Barker is a Senior Scientist and Lab Leader at Denali Therapeutics. She joined Denali as a preclinical translational scientist with a focus on developing and optimizing the oligonucleotide delivery platform, OTV. She has been passionate about understanding and treating neurodegenerative disorders since her academic years, and is happy to be working with a superb team at the forefront of brain delivery technology.